Invisible Bacteria Threat: WHO's 2024 Bacterial Priority Pathogens List Explained
An introduction to antibiotic research and development (R&D)
WS 23 - Partnerships and Antimicrobial Resistance
Animal models to study the activity of antibiotics
PD 15 - Confronting AMR: Sustainable Antibiotic R&D, Equitable Access and Responsible Stewardship
Antimicrobial Resistance - Too many bugs, not enough drugs! | ARMoR | EAGxVirtual 2024
Non traditional antibacterial therapeutic options and challenges
2020 WSC Spotlight – Antimicrobial Resistance: An Emerging Global Health Threat
The approaching antibiotic apocalypse: new strategies to combat old foes
NIAID Resources to Facilitate Discovery & Development of Anti Infectives
Webinar 7 July 2022 - Breaking down access barriers for antibiotics: Cefiderocol as a pathfinder
Advancing Bacterial Diagnostic Development Webinar
1/5/21 - Examining the Long-term Health & Economic Effects of Antimicrobial Resistance in the U.S.
PU Livestream: Physical Science - Class 4: Combating Antibiotic-Resistant Bacteria
Antibacterial drugs: Clinical development for non-developers, part 2 – Single pathogens
Superbugs: Slowing the Spread of Antibiotic-Resistant Bacteria
Communicable E3 - The new WHO Priority Pathogens List: which bugs to target first?
Advancing antibiotic R&D during the COVID 19 pandemic
SDRI 2017 - Top three AMR research priorities panel session
